Get started
JOHNSON & JOHNSONJOHNSON & JOHNSONJOHNSON & JOHNSON

JOHNSON & JOHNSON

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

JNJ trade ideas

Bullish JNJ COVID Vaccine developmentJNJ has been aiding in developing their own covid vaccine and will have phase 2 FDA approval mid to end of September which can lead to positive growth overall in this strong company. TA shows that price is forming an ascending triangle which has a bullish sentiment and is projected to breakout around mid next year. Good potential LEAP or Holding of shares long term. (leaning toward LEAP slightly out of the money expiring Jan 21, 2022. 170c @ 460 a contract)
NYSE:JNJLong
by Zenith_Investment
JNJ - buy support zone (gray) analysisHello traders, Description of the analysis: Johnson & Johnson ( JNJ ) support zones ideal for timing long positions (gray). Trade what you understand, trade carefully and sparingly according to the business plan. About me: Hi, my name is Jacob Kovarik and I´m trading on stock exchange since 2008. I started with a capital of 3000 USD. My first strategy was based on OTM options. (American stock index and their ETF ). I´ve learnt on my path that professional trading is based on two main fundaments which have to complement each other, to make a bussiness attitude profitable. I´ve tried a lot of techniques and many manners how to analyze the market. From basic technical analysis to fundamental analysis of single title. My analytics gradually changed into professional attitude. I work with logical advantages of stock exchange (return of value back to average, volume , expected volatility , advantage of high stop-loss, the breakdown of time in options, statistics and cosistent thorough control of risk). At the moment, my main target is ITM on SPM index. Biggest part of my current bussiness activity comes from e mini futures (NQ, ES). I´m trader of positions. I´m from Czech republic and I take care of a private fund (over $4.000.000 USD). During my career I´ve earned a lot of valuable experience, such as functionality of strategies and what is more important, control of emotions. Professional trading is, in my opinion, certain kind of mental training and if we are able to control our emotions, accomplishment will show up. I will share with you my analysis and trades on my profile. I wish to all of you successul trades. Jacob
NYSE:JNJLong
by Jacob_Kovarik
1
JOHNSON & JOHNSON VACCINE D1Johnson & Johnson was the first American company to develop a vaccine against the corona virus. More than 20 companies took part in the race for a panacea. But only Johnson was able to achieve significant results. The company conducted tests on animals (monkeys). They started to develop antibodies. The government gave the company $ 456 million to test people and speed up the manufacturing process. This disease has spread all over the world and more than 20,000,000 people need this drug. This vyktsin can become a product of the year and create a huge stir among the violence of the entire planet. The United States is in particular need for the drug. The country with the highest incidence rate. The country's government has already signed a $ 1 billion deal with the company. And most likely this is not the last contract for the company. Such profit of the company cannot but stimulate the stock to rise. Therefore, for Johnson and Johnson, this vaccine can become a gold source of income.
NYSE:JNJLong
by TradingForProfitPro
J&JOHNSON, Flag-Formation Confirmed, Continuation Possible!Hello Traders Investors And Community, welcome to this update-analysis about JOHNSOHN & JOHNSON stock value 4-hour timeframe perspectives where I made an analysis some time ago and therefore we look at the confirmational events happened, the current structure and what to expect next times from this stock. The bull-flag I mentioned in the initial analysis now fully confirmed to the upside and the wave-count ended at the 800-EMA which provided the starting point to break out of the bull-flag and form these nice impulses where the first bull-flag-target will be reached soon at the 155.5 level which is slightly above the all-time-high, as this is an important zone where also supply can enter the market I detected the importance in the current structure we should consider now to anticipate where the journey for this stock is heading. In my chart, you can watch that the stock is just to complete its second impulse to the upside which is ending at the first bull-flag-target at 155.5 and above the all-time-high-condition, this level is crucial in many places as this can turn out the be a possible bull-trap as supply entering the market, normally what happens when the market approaches such key-levels is minium a correction when not bigger pull-back before backing up and approaching the level again. When the stock shows up with this likely scenario we can expect the pull-back to go to the 100-EMA marked in my chart in green where the stock can stabilize and gain strength in sideways movement before moving up to form a breakout which can confirm the further bullish rising, in this case, it is important that the stock moves above the established all-time-highs with great volatility. Overall the stock has established some decent and solid bullishness here where it is also trading above the EMAs mentioned important to determine the strongness of stocks in the current mixed market situation, only when the stock crosses below the 100-EMA this can invalidate the bullish scenario, nevertheless, there is a higher possibility given that this support will hold sustainable and new highs will be seen which will activate the middle and long term bull-flag-target. Compared to other stocks and the main market JNJ is in a more bullish situation where many others still trading way below the pre-corona all-time-highs and looking rather weak then strongly bullish, we will see how this situation will develop in this stock-value here, overall the bullishness can go on further after the correction has settled in and the stock gained more strength to form a solid breakout. In this manner, thank you for watching, support for more market insight, all the best! "There are many roads to prosperity, but one must be taken." Information provided is only educational and should not be used to take action in the markets.
NYSE:JNJ
by VincePrince
1
JOHNSON & JOHNSON D1 VACCINE FOR CORONO VIRUSJohnson & Johnson pioneered and tested the Corono Virus vaccine. The monkeys received the first vaccines. Six and six monkeys received protection for their lungs. And five individuals began to develop antibodies. The US government has committed $ 456 million to accelerate vaccine development. In the near future, this vaccine will be tested in humans. America is now the epicenter of the epidemic. And the government is doing everything it can to save the violence, preventing mass deaths. Although with the current situation in the United States, it is very difficult to succeed. But if the company does everything to bring its experiment to the desired effect. This will help her make a fortune. And against the backdrop of such prospects, the stock will certainly rise rapidly.
NYSE:JNJLong
by StrongBull777
Johnson & Johnson D1Following encouraging results from Johnson & Johnson's experimental vaccine test in monkeys showing that a single dose is sufficient to protect them from the coronavirus, the final human trial of the vaccine began in the United States on Thursday. The test results were published in the scientific journal Nature, and according to the article, 6 out of 6 monkeys who were injected with the vaccine received full protection against lung disease, and 5 out of 6 also developed antibodies that protect against coronavirus infection. Dr. Paul Stoffels, chief scientist at J&J, said it would be possible to test a single dose of the vaccine in humans and see if it has a protective effect against the virus. Stoffels believes that a single dose of the vaccine has a significant advantage in eliminating the logistical cost of getting people back to the clinic to re-administer the vaccine. J&J has received government aid in the amount of $ 456 million in a government program aimed at accelerating the production of a vaccine to combat the coronavirus pandemic. The company plans to begin a large-scale third phase with a single dose of vaccine in the second half of September. A study with two doses of vaccine will begin around the same time. If the company nevertheless brings the experiment to its logical conclusion, this device may become a gold mine for it. And the company's capitalization will skyrocket just like the stock price.
NYSE:JNJLong
by fx_space_coach